A case of central diabetes insipidus after COVID-19 as a probable diagnosis of lymphocytic infundibulo-neurohypophysitis with positive anti-rabphilin-3A antibodies with review of literature.

Publication date: Dec 02, 2024

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2, and various complications have been reported. Furthermore, there have been increasing reports of endocrinopathy related to COVID-19 following the pandemic. We report a 49-year-old healthy woman who developed rapid onset of polydipsia and polyuria three weeks after COVID-19. Laboratory tests indicated low urine osmolarity and increased serum osmolarity, and antidiuretic hormone (ADH) was undetectable. Urine osmolality remained low with water deprivation. Similarly, plasma ADH responses to hypertonic-saline infusion were blunted and urine osmolality increased in response to desmopressin. There was no clear evidence of anterior pituitary dysfunction. T1-weighted magnetic resonance imaging (MRI) showed pituitary stalk thickening and absence of posterior pituitary bright signal spots, suggesting the presence of hypophysitis. Based on these results, we made a probable diagnosis of lymphocytic infundibulo-neurohypophysitis (LINH) which have caused central diabetes insipidus. Positive findings for serum anti-rabphilin-3A antibodies, reported as a potential diagnostic marker for LINH, were also noted. Following oral desmopressin administration, polydipsia and polyuria were quickly improved, though treatment with desmopressin was still required over four months. This is the first report of a patient with a probable diagnosis of LINH after COVID-19 who tested positive for anti-rabphilin-3A antibodies. Positive findings for those antibodies suggest that pituitary dysfunction associated with COVID-19 is hypophysitis involving an abnormal immune mechanism. The presence of anti-rabphilin-3A antibodies may be useful as a non-invasive diagnostic marker of LINH and potentially serve as a valuable diagnostic aid in cases of LINH associated with COVID-19.

Concepts Keywords
Clear Anti-rabphilin-3A antibodies
Coronavirus Autoantibodies
Diabetes Autoantibodies
Months Autoimmune Hypophysitis
Mri Central diabetes insipidus
Coronavirus disease 2019 (COVID-19)
COVID-19
Diabetes Insipidus, Neurogenic
Female
Humans
Lymphocytic infundibulo-neurohypophysitis
Magnetic Resonance Imaging
Middle Aged
SARS-CoV-2

Semantics

Type Source Name
disease MESH central diabetes insipidus
disease MESH COVID-19
disease MESH complications
drug DRUGBANK Water
drug DRUGBANK Desmopressin
disease MESH hypophysitis
disease MESH Long Covid
disease MESH Autoimmune Hypophysitis

Original Article

(Visited 2 times, 1 visits today)